The 8 analysts offering 12-month price forecasts for Arcturus Therapeutics Holdings Inc have a median target of 24.00, with a high estimate of 32.00 and a low estimate of 18.00. The median estimate represents a +80.18% increase from the last price of 13.32.
The current consensus among 8 polled investment analysts is to Buy stock in Arcturus Therapeutics Holdings Inc. This rating has held steady since March, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.59
Reporting Date May 18
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.